2021
DOI: 10.1016/s2213-2600(21)00370-2
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 vaccines: addressing hesitancy in young people with allergies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 8 publications
1
9
0
1
Order By: Relevance
“…Although vaccination has dramatically improved the control of COVID-19 transmission [ 11 ], vaccination hesitancy remains a significant issue owing to adverse reactions, particularly unpredictable hypersensitivity reactions [ 12 , 13 ]. Most hypersensitivity reactions to vaccines occur immediately and abruptly within minutes to hours after administration [ 14 , 15 , 16 ].…”
Section: Clinical Phenotypes Of Vaccine-induced Immediate Hypersensit...mentioning
confidence: 99%
“…Although vaccination has dramatically improved the control of COVID-19 transmission [ 11 ], vaccination hesitancy remains a significant issue owing to adverse reactions, particularly unpredictable hypersensitivity reactions [ 12 , 13 ]. Most hypersensitivity reactions to vaccines occur immediately and abruptly within minutes to hours after administration [ 14 , 15 , 16 ].…”
Section: Clinical Phenotypes Of Vaccine-induced Immediate Hypersensit...mentioning
confidence: 99%
“…63 As reports of allergic reactions to the mRNA COVID-19 vaccines emerged early in the pandemic, there is a common concern among allergic families, including families of adolescents with asthma, about the risk of an allergic reaction to the COVID-19 vaccine. 64 Whereas the incidence of anaphylaxis posteCOVID-19 vaccines is estimated at approximately 7.91 cases per million doses, 65 which is higher than the historical incidence of vaccine anaphylaxis overall (of 1.3 cases per million doses), 66 this remains an exceptionally rare outcome and, thus far, there has been no long-term morbidity nor mortality associated with COVID-19 vaccine anaphylaxis. Although those who have reported allergic reactions to the COVID-19 vaccine commonly have selfreported prior allergic conditions, these conditions are common in the general population, and the risk is impossible to quantify because the rate of individuals with allergic conditions who have tolerated the COVID-19 vaccine is not available.…”
Section: School Attendance-covid-19 Vaccinationmentioning
confidence: 99%
“…In a study in South Korea, 76.5% of parents intended to get vaccinated and 64.2% intended to have their children vaccinated, but only 49.6% of children responded that they would get COVID-19 vaccination [ 125 ]. Among European adolescents, a history of allergies, migration background and female gender were associated with greater vaccine hesitancy [ 126 , 127 ]. In Qatar, the parents of 12-year-old adolescents were more hesitant (22%) compared to the 13-year-olds (16%) and 15-year-olds (15%).…”
Section: Caregivers’ Willingness To Vaccinate Minors Opinions Among Adolescents and Vaccine Hesitancementioning
confidence: 99%